Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III recombinant zoster vaccine (CHO cell) trial in adults aged 40 years and older
ChiCTR2400085861Phase 3Not yet recruiting
- Sponsor
- Henan Center for Disease Control and Prevention
- Start
- Jun 2024
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Zoster vaccine recombinant in herpes zoster (HZ) (2 arms), sponsored by Henan Center for Disease Control and Prevention. Primary endpoint: Incidence of confirmed herpes zoster cases per person-years in subjects aged 40 years and older. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on ChiCTR2400085861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085861.